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Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic progressively fatal disease. Extracellular Matrix
Metalloproteinase Inducer (EMMPRIN) is a glycosylated transmembrane protein that induces the expression of some
matrix metalloproteinase (MMP) in neighboring stromal cells through direct epithelial–stromal interactions.
EMMPRIN is highly expressed in type II alveolar epithelial cells at the edges of the fibrotic areas in IPF lung sections.
However, the exact role of EMMPRIN in IPF is unknown.
Methods: To determine if EMMPRIN contributes to lung fibroblast proliferation, resistance to apoptosis, and
differentiation to myofibroblasts, normal Human lung fibroblasts (NHLF) transiently transfected with either
EMMPRIN/GFP or GFP were treated with TGF- β1 from 0 to 10 ng/ml for 48 h and examined for cell proliferation
(thymidine incorporation), apoptosis (FACS analysis and Cell Death Detection ELISA assay), cell migration (Modified
Boyden chamber) and differentiation to myofibroblasts using Western blot for α–smooth actin of cell lysates. The
effect of EMMPRIN inhibition on NHLF proliferation, apoptosis, migration and differentiation to myofibroblasts after
TGF- β1 treatment was examined using EMMPRIN blocking antibody. We examined the mechanism by which
EMMPRIN induces its effects on fibroblasts by studying the β-catenin/canonical Wnt signaling pathway using Wnt
luciferase reporter assays and Western blot for total and phosphorylated β-catenin.
Results: Human lung fibroblasts overexpressing EMMPRIN had a significant increase in cell proliferation and
migration compared to control fibroblasts. Furthermore, EMMPRIN promoted lung fibroblasts resistance to
apoptosis. Lung fibroblasts overexpressing EMMPRIN showed a significantly increased expression of α- smooth
muscle actin, a marker of differentiation to myofibroblasts compared to control cells. TGF-β1 increased the
expression of EMMPRIN in lung fibroblasts in a dose-dependent manner. Attenuation of EMMPRIN expression with
the use of an EMMPRIN blocking antibody markedly inhibited TGF-β1 induced proliferation, migration, and
differentiation of fibroblasts to myofibroblasts. EMMPRIN overexpression in lung fibroblasts was found to induce an
increase in TOPFLASH luciferase reporter activity when compared with control fibroblasts.
Conclusion: These findings indicate that TGF-β1 induces the release of EMMPRIN that activates β-catenin/canonical
Wnt signaling pathway. EMMPRIN overexpression induces an anti-apoptotic and pro-fibrotic phenotype in lung
fibroblasts that may contribute to the persistent fibro-proliferative state seen in IPF.
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Background
Idiopathic pulmonary fibrosis (IPF) is a progressive inter-
stitial lung disease with median survival time of about
3 years from initial diagnosis [1]. IPF is characterized by
the progressive and ultimately excessive accumulation of
mesenchymal cells (including fibroblasts and their dif-
ferentiated phenotype, myofibroblasts) and extracellular
matrix in the lung [2]. An important feature of IPF is the
presence of fibroblastic foci throughout the entire lung
[3]. Several studies have demonstrated a paucity of apop-
tosis of the fibroblasts within the fibroblastic foci in IPF
[4, 5]. Moreover, fibroblasts from fibrotic lungs are resist-
ant to a variety of apoptotic stimuli [6, 7]. IPF fibroblasts
also acquire an invasive phenotype and are able to invade
artificial basement membranes more readily than normal
fibroblasts [8]. TGF-β1 is strongly implicated in the pa-
thogenesis of lung fibrosis. TGF-β1 has been shown to
promote the induction of an apoptosis resistant phenotype
of fibroblasts [9, 10]. Furthermore, it is a critical regulator
of fibroblast differentiation into activated myofibroblast
[11, 12]. TGF- β1 is secreted by several cells including
type II alveolar epithelial cells (AEC), and usually secreted
in an inactive form attached to a latency-associated
peptide [13]. Certain MMPs such as MMP-2, MMP-9,
and MT1-MMP have been shown to activate latent
TGF- β1 [14–18].
Extracellular matrix metalloproteinase inducer (EMM-
PRIN), also known as CD147 or basigin is a trans-
membrane glycoprotein expressed on epithelial cells that is
responsible for the induction of MMPs in neighboring
stromal cells through direct epithelial–stromal interactions
[19–22]. EMMPRIN is expressed in type II alveolar epithe-
lial cells at the edges of the fibrotic areas in IPF lung
sections [23] and its expression is associated with an
induction of MMP-1, -2, -3, -9 as well as α-SMA in the
neighboring stromal area [24] implying a role of EMM-
PRIN in IPF epithelial-stromal interactions [22, 23, 25]. Re-
cently, more direct evidence demonstrated the involvement
of EMMPRIN in fibroblast differentiation to myofibroblasts
by inducing α-SMA expression in an MMP independent
manner [22, 25]. Furthermore, EMMPRIN has been shown
to have a regulatory role over the Wnt/β -catenin signaling
pathway [26]. Silencing EMMPRIN inhibited β -catenin sig-
naling, cell migration, proliferation, anchorage-independent
growth and tumor growth in a mouse tumor xenograft
model [26]. WNT/ β -catenin signaling pathway has been
shown to play a major role in the development of experi-
mental and human pulmonary fibrosis [27].
In this study we demonstrate that EMMPRIN
overexpression in human lung fibroblasts contributes
to a pro-fibrotic phenotype of fibroblasts by inducing
fibroblast proliferation, survival, migration and differ-
entiation to myofibroblast possibly through activating
β-catenin/canonical Wnt signaling pathway.
Methods
Cell culture
Normal human lung fibroblasts (NHLF) were purchased
from Lonza Walkersville Inc. (Walkersville, MD) and
were cultured in Dulbecco’s modified Eagle medium
(DMEM) (Invitrogen, Carlsbad, CA, USA) with 10 %
fetal bovine serum, and 1 % penicillin/streptomycin
(Invitrogen). Cells from passages 5 to10 were used in all
experimental studies.
Transfection of EMMPRIN
Transient transfection of NHLF with EMMPRIN was
achieved as previously described [28].
a) Construction of the plasmids.
A 1.6 kb length of cDNA representing the entire EMM-
PRIN sequence encoding 269 amino acid residues was
placed in an EcoRI site under the control of the cyto-
megalovirus (CMV) promoter in pcDNA3 (a mammalian
expression vector used for efficient expression; Invi-
trogen). To facilitate identification of transfected cells in
vitro, green fluorescent protein (GFP) GFPmut1variant
cDNA (Clontech Laboratory, Inc., Palo Alto, CA, USA)
was inserted into the EMMPRIN-containing plasmid. The
GFP cDNA along with a separate upstream CMV pro-
moter from enhanced GFP plasmid-C1 were inserted into
EMMPRIN expression vectors. An additional polyadenyla-
tion signal from pSG5 (Stratagene, La Jolla, CA, USA) was
placed downstream of the EMMPRIN gene to provide
balanced expression of both recombinant genes under
control of CMV promoters. The resulting plasmids
were named EMMPRIN/GFP. As a control plasmid,
GFP cDNA alone was subcloned into pcDNA3 with-
out EMMPRIN cDNA.
b) Transient transfection of human lung fibroblasts.
Human lung fibroblasts grown in 35 mm tissue-culture
plates were cultured in 2 ml 10 % serum-DMEM media
and incubated for 24 h. with 150nM NaOH containing
polyethylenimine (PEI), and pcDNA, expressing EMM-
PRIN complexes, or control vector. The cells were
then washed with PBS and cultured in DMEM media
containing 10 % FBS. The efficiency of transfection
was based on immunoblotting assay using EMMPRIN
monoclonal antibodies (Chemicon International, Temecula,
CA) and MMP release using gelatin zymography to assess
MMP-2 and -9.
TGF-β1 and EMMPRIN functional blocking antibody
treatment
NHLF were plated in 6 well plates in DMEM supple-
mented with 10 % FCS and cultured until 70 – 80 %
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confluent. Cells were subjected to starvation by washing
cells twice with serum free DMEM for 2 h, followed by
the addition of DMEM and 0.01 % bovine serum albu-
min (BSA) to each well. Cells were treated with TGF- β1
(R&D, Minneapolis, MN) in a dose from 0 to 10 ng/ml
for 24 h. In some experiments, NHLF were induced to
undergo programmed cell death by incubation with
50nM staurosporine (STS) for 3 h prior to the end of
the experiment. Additionally, NHLF were cultured in
the presence of either the EMMPRIN functional block-
ing antibody (100 ng/ml) or IgG control antibody
(Research Diagnostics, Inc., Flanders, NJ) to confirm the
effects of EMMPRIN on NHLF cells.
Apoptosis assays
a) Annexin V-FITC/propidium iodine (PI) staining:
NHLF were treated for 24 h in serum-free medium
under the described conditions. Detached cells were
collected by centrifugation. Cells were resuspended
in Annexin V binding buffer (BD Biosciences, San
Diego, CA, USA). Cells were then incubated with
Annexin V-FITC and PI for 15 min at room
temperature. Cells were analyzed and quantified by
flow cytometry.
b) Cell Death Detection ELISA assay: Fragmentation of
DNA after cell death was determined by photometric
enzyme immunoassay (Cell Death Detection
ELISAPLUS, Roche Applied Science) per manufacturers
instruction. Briefly, NHLF from the different treatment
conditions were lysed using lysis buffer and centrifuged
at 200 × g, and cytoplasmic fractions were transferred
to streptavidin-coated plates that had been incubated
with a biotinylated, monoclonal anti-histone antibody.
The amount of fragmented DNA of nucleosomes
bound to anti-histone antibody was evaluated by
peroxidase-conjugated monoclonal anti-DNA
antibody and the plates were read at 405 nm
on a spectrophotometer.
Proliferation assays
NHLF from different treatment conditions were exam-
ined for cell proliferation using [3H] Thymidine incorp-
oration to assess DNA synthesis rates. Eight hours prior
to the end of the experiment, 1 μCi/ml [3H] thymidine
was added to NHLF. After 8 h of incubation at 37 °C,
the conditioned media were aspirated. The cells were
washed twice with PBS at 4 °C, and cold 5 %
trichloroacetic acid was added for 30 min to precipitate
protein and DNA. The precipitates were washed with
cold water and re-suspended in 0.5 ml 1 M NaOH, and
then 0.4 ml aliquots were added to 4 ml scintillation
fluid and counted in a scintillation counter (Packard
Instrument, Downers Grove, IL, USA).
Cell viability assays
NHLF from each experimental group were examined for
cell viability using Cell Titer-Glo® Luminescent Cell
Viability assay (Promega Corporation, Madison, WI)
following the manufacturer’s instructions.
Migration assay using a modified Boyden chamber assay
NHLF overexpressing EMMPRIN or GFP were exam-
ined for their ability to migrate in the presence TGF-β1
using a modified Boyden chamber assay. The migration
assays were performed with transwell (Costar, Corning,
NY, USA) 24-well tissue-culture plates composed of
polycarbon membranes with 8 μm pores. EMMPRIN or
GFP lung fibroblasts were seeded on the upper
chambers of the transwells at 1 × 105 cells in 100 μl
DMEM media containing 0.1 % BSA. TGF-β1 in doses
of 0 to10 ng/ml was added to the lower chambers. The
transwells were incubated for 24 h at 37 °C in a CO2
incubator. The number of cells that migrated to the
lower surface of the membrane was counted under 200×
magnification. Ten high-power, random fields were
counted per sample. Each group was run in triplicate.
Western blotting
Protein concentration of cell lysates was determined by
BCA. Equal amounts of proteins (20 μg) of cell lysates
were resolved in 8-16 % SDS-PAGE and transferred onto
a nitrocellulose membrane (Amersham Biosciences,
Pittsburgh, PA). After blocking with 5 % milk, the
membranes were incubated with primary antibodies
overnight at 4 °C followed by incubation with horserad-
ish peroxidase-conjugated secondary antibodies and
detection by use of an enhanced chemiluminescence
detection system (Amersham Biosciences, Pittsburgh,
PA). Primary antibodies included mouse monoclonal
anti- α-SMA (1:10000 dilution, Sigma Aldrich), anti-
human EMMPRIN (1:1000 dilution, Santa Cruz Bio-
technology), rabbit polyclonal anti-Caspase 3 (1:500
dilution, Santa Cruz Biotechnology), rabbit polyclonal
anti β-Catenin (1:1000 dilution, Abcam, Cambridge, MA)
and β-Tubulin (1:200 dilution; Santa Cruz Biotechnology).
Band densities were digitalized and quantified using image
analysis software. Results were expressed as a ratio of
band density to total β-tubulin.
Gelatin zymography
Gelatin zymography of conditioned media was performed
as described previously [28]. Briefly, conditioned media
from the different treatment conditions were diluted 1:1
in non-reducing sample buffer and separated on 10 % SDS
polyacrylamide gels containing 0.1 % gelatin (Invitrogen)
for 150 min at 125 V. SDS was removed by incubation
with renaturing buffer (Triton X-100, 2.5 % diluted in
water) for 30 min at room temperature. The gels were
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washed for 30 min in developing buffer (Invitrogen) and
then incubated overnight at 37 °C in fresh developing
buffer. Finally, gels were stained with Coomassie blue.
Zones of enzymatic (gelatinolytic) activity were character-
ized by the absence of Coomassie blue.
Wnt luciferase reporter assays
NHLF overexpressing EMMPRIN/GFP or GFP alone were
plated at a density of 5x104 cells/well in a 12-well plate.
Cells were transfected with TOPFLASH or FOPFLASH
and a renilla luciferase plasmid (Promega, Madison, WI)
as a control for transfection efficiency. Transfection of
plasmid DNA into cells was achieved using polyethyleni-
mine (PEI) and NaCl (Biosciences, San Jose, CA). Cells
were cultured in DMEM containing 10 % FBS. TGF-β1
was added to the fibroblasts one day after transfection.
Cells were harvested 72 h after transfection, and luciferase
activity was assayed using the Dual Luciferase Assay kit
(Promega, Madison, WI) according to the user’s manual.
Luciferase activity was normalized to renilla activity.
Statistical analysis
All results were reported as mean ± SEM. ANOVA for
repeated measures was used to assess differences
amongst conditions when multiple time-points were
compared. Students’ t- test for unpaired data was used
to assess the difference between conditions. P < 0.05 was
considered to be significant.
Results
EMMPRIN overexpression in human lung fibroblasts
induces a pro-fibrotic phenotype of fibroblasts
EMMPRIN overexpression was confirmed in NHLF cells
by detecting GFP using fluorescent microscopy, protein
expression of EMMPRIN via western blot, and MMP-2
activation using gelatin zymography (Fig. 1a-c). As
expected, NHLF cells overexpressing EMMPRIN ex-
hibited a significant increase in cell proliferation as
evidenced by increased thymidine incorporation at 48 h
compared to control GFP cells (p < 0.001; Fig. 2a). TGF-β1,
in a dose-dependent manner, significantly increased thymi-
dine incorporation into both EMMPRIN overexpressing
fibroblasts and GFP control cells (p < 0.001; Fig. 2a).
To examine the effects of EMMPRIN on the migratory
capacity of the lung fibroblasts, the cell migration assay
was carried out using a modified Boyden chambers with
8-μm pore membrane inserts. EMMPRIN overexpression
in NHLF induced a significant increase in cell migration
when compared to control GFP stable cells (p < 0.001;
Fig. 2b). TGF-β1, in a dose-dependent manner, significantly
increased cell migration of both EMMPRIN overexpressing
fibroblasts and GFP control cells (p < 0.05; Fig. 2b).
Differentiation of lung fibroblasts to myofibroblasts was
assessed by analyzing α- smooth actin. Our results demon-
strate that NHLF overexpressing EMMPRIN had a signifi-
cant increase in α- smooth actin expression compared to













Fig. 1 EMMPRIN overexpression in normal human lung fibroblasts (NHLF): NHLF were transiently transfected with either EMMPRIN/GFP or GFP
alone and assessed for EMMPRIN expression using (a) Fluorescent microscopy demonstrating the distribution of GFP throughout the cell (left
panel) in GFP control cells, while EMMPRIN-GFP cells primarily display cell-surface GFP expression (right panel). White Bar = 50 um. b Western blot
analysis and (c) Gelatin zymography for MMP-2 release and activation (n = 10)
Hasaneen et al. Respiratory Research  (2016) 17:17 Page 4 of 14
expression of α- smooth actin in EMMPRIN overexpressing
NHLF compared to GFP transfected control cells (Fig. 2c).
EMMPRIN induces resistance of human lung fibroblasts to
apoptosis
To determine the effect of EMMPRIN on NHLF survival,
EMMPRIN/GFP and GFP transfected NHLF treated with
TGF- β1 were examined for apoptosis using FACS analysis
and a cell death detection ELISA assay. As shown in
Fig. 3a-c, EMMPRIN overexpression in NHLF inhibited
both (Annexin V+/PI-) early and (Annexin V+/PI+) late
apoptosis as compared to GFP control NHLF. There was
no significant difference in (Annexin V-/PI +) cell necrosis





































































Fig. 2 EMMPRIN overexpression induces phenotypic changes in normal human lung fibroblasts. Growth arrested NHLF transiently transfected
with either EMMPRIN/GFP or GFP were treated with TGF- β1 5 and 10 ng/ml for 48 h. a Cell proliferation was assessed by thymidine
incorporation. b Cell migration using Modified Boyden chamber. Each bar represents means ± SEM of 3 independent experiments each run in
duplicates. ** p < 0.001 comparing GFP to EMMPRIN/GFP transfected cells, # p < 0.01 Comparing TGF- β1 treated cells to control. c A
representative Western blot for α – smooth actin (α-SMA) of cell lysates from EMMPRIN/GFP and GFP control cells in the presence and absence
of TGF-β1. β-Tubulin was used as the loading control. Image is representative of 3 independent experiments each run in duplicate
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Fig. 3 (See legend on next page.)
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control cells (Fig. 3a & b). TGF- β1 significantly
inhibited both early and late apoptosis only in GFP
transfected NHLF (p < 0.05; Fig. 3b & c). Next we ex-
amined the effect of EMMPRIN on fibroblast survival
during STS induction of apoptosis. STS is a broad
spectrum protein kinase inhibitor that inhibits numer-
ous Ser/Thr and Tyr kinases, which triggers cell
death. STS has been shown to induce fibroblast apop-
tosis in cells from patients with pulmonary fibrosis
[29, 30]. Treatment of NHLF overexpressing EMM-
PRIN with STS resulted in a significant decrease in
the percentage of apoptotic cells compared to GFP
control cells treated with STS (Fig. 3a and c). TGF-β1
treatment had no significant effect on the percentage
of apoptosis of both GFP and EMMPRIN transfected
NHLF in the presence of STS (Fig. 3c). This finding
shows that EMMPRIN inhibits fibroblast apoptosis in
the presence of apoptotic stimulus independent of
TGF- β1.
TGF–β1 increases EMMPRIN expression and MMP-2
activation in human lung fibroblasts
We examined in these experiments whether TGF-β1 in-
duced NHLF proliferation, migration and differentiation
was associated with EMMPRIN expression. Our results
demonstrated that exposing NHLF to TGF-β1 was asso-
ciated with an increase in the expression of EMMPRIN
(Fig. 4a), MMP-2 activation (Fig. 4b).
EMMPRIN functional blocking antibody induces apoptosis
in human lung fibroblasts
Finding that TGF-β1 induces EMMPRIN expression in
NHLF, we sought to determine if EMMPRIN inhibition
could enhance NHLF susceptibility to apoptosis. NHLF
were treated with TGF- β1 in the presence of either
EMMPRIN functional blocking antibody or IgG anti-
body for 24 h. TGF-β1 inhibited apoptosis of NHLF in a
dose dependent manner. EMMPRIN functional blocking
antibody also abrogated the effect of TGF-β1 on NHLF.
(See figure on previous page.)
Fig. 3 EMMPRIN overexpression induces resistance of normal human lung fibroblasts to apoptosis: Growth arrested NHLF overexpressing either
EMMPRIN/GFP or GFP were treated with TGF- β1 from 0 to 10 ng/ml for 24 h in the presence and absence of 0.5 mM of Staurosporine (STS)
added for 3 h prior to the end of the experiments. Apoptosis was measured by FACS analysis (a-b) using annexin V/PI staining and cell death
detection ELISA assay (c). Relative apoptosis is expressed as a percentage of the assay-positive control that was run on the ELISA plate
for each experiment. All samples were run in triplicate for each ELISA and FACS analysis. ** p < 0.001 comparing GFP to EMMPRIN/GFP
transfected cells (n = 3 independent experiments)
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Fig. 4 TGF-β1 induces EMMPRIN Expression and MMP-2 activation in normal human lung fibroblasts; inhibition of MMP-2 activation by EMMPRIN
functional blocking antibody: (a) A representative Western blot showing the expression of EMMPRIN in the cell lysates from NHLF stimulated with
TGF-β1 compared to control untreated cells. β-Tubulin was used as the loading control. b A representative zymography demonstrating MMP-2
activation in the conditioned media from NHLF stimulated with TGF-β1 compared to the control untreated cells and inhibition of MMP-2
activation by EMMPRIN functional blocking antibody (n = 3 independent experiments, each run in duplicate)
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Fig. 5 (See legend on next page.)
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The EMMPRIN functional blocking antibody induced an
increase in the percentage of early and late apoptotic
NHLF only after TGF- β1 treatment (Fig. 5a and b).
EMMPRIN blocking antibody treatment of NHLF abro-
gated the survival effect of TGF- β1 on NHLF and
restored the expression of caspase 3 protein close to
control levels (Fig. 5c). To confirm that the EMMPRIN
functional blocking antibody inhibits EMMPRIN induc-
tion by TGF- β1, we examined MMP-2 release and activa-
tion in the conditioned media using gelatin zymography.
Our results showed that TGF- β1 treatment induced an
increase in MMP-2 release/activation and EMMPRIN
functional blocking antibody inhibited MMP-2 activities
returned it to control levels (Fig. 4b).
TGF-β1 induces human lung fibroblast proliferation,
migration and differentiation to myofibroblast: Inhibition
by EMMPRIN functional blocking antibody
As shown in Fig. 6a, TGF-β1 significantly induced an in-
crease in NHLF proliferation as evidenced by increased
thymidine incorporation (p < 0.05). The EMMPRIN
blocking antibody significantly inhibited TGF- β1 in-
duced fibroblast proliferation. Using a transwell migra-
tion assay, TGF-β1 significantly induced an increase in
NHLF cell migration and EMMPRIN functional blocking
antibody significantly inhibited TGF- β1 induced NHLF
migration (Fig. 6b). TGF-β 1 significantly induced an
increase in NHLF differentiation to myofibroblasts as
evidenced by an increase in α-smooth muscle actin.
Similar to proliferation and migration, EMMPRIN block-
ing antibody significantly inhibited TGF- β1 induced
fibroblast differentiation to myofibroblasts (Fig. 6c).
These results imply that the effects of TGF- β1 on
NHLF behavior can be attributed to an increase in
EMMPRIN expression.
Overexpression of EMMPRIN in NHLF results in activation
of a Wnt/β-catenin signaling pathway
WNT/ β -catenin signaling pathway has been shown
to play a major role in the development of experi-
mental and human pulmonary fibrosis [27]. To ex-
plore the mechanism by which EMMPRIN enhances
NHLF proliferation, migration, and differentiation, we
examined the active status of β-catenin, which is an
important factor in the canonical Wnt signaling path-
way that can be induced by TGF- β1. Immunoblotting
studies demonstrated an increased expression of phos-
phorylated β-catenin in cell lysate from EMMPRIN over-
expressing NHLF compared to GFP transfected control
cells. TGF-β1 treatment of EMMPRIN overexpressing
NHLF further increased the expression of β- catenin
(Fig. 7a). To validate the functional significance of
increased β-catenin expression, Wnt signaling activity was
measured by luciferase expression controlled by TOP-
FLASH. EMMPRIN overexpression in NHLF was found
to induce an increase in TOPFLASH luciferase reporter
activity when compared with GFP control-transfected cells
(Fig. 7b). TGF-β1 treatment of EMMPRIN overexpressing
cells induced an increase in TOPFLASH luciferase
reporter activity when compared with GFP control
cells (Fig. 7b).
Discussion
EMMPRIN, which is usually expressed on tumor cells of
epithelial origin, is responsible not only for induction of
MMPs in neighboring stromal cells but also for trans-
formation of quiescent fibroblasts to cancer-associated
fibroblasts through direct tumor–stromal interactions
[25]. Apart from its role on cancer cells, EMMPRIN
expression is increased not only in lung fibrosis [23], but
also in other types of tissue fibrosis including renal
fibrosis [31], hepatic fibrosis [32] and corneal wound
healing response [33]. EMMPRIN expression in all these
situations is mainly localized in actively differentiating
basal epithelial layer implying a role of EMMPRIN in
epithelial stromal interactions [22]. The precise regulatory
mechanism of EMMPRIN in lung fibrosis has not been
elucidated. In this study, we examined EMMPRIN’s role
in the regulation of pro-fibrotic phenotypic changes in hu-
man lung fibroblast by studying fibroblasts proliferation,
migration, differentiation, and resistance to apoptosis. We
present evidence that EMMPRIN overexpression signifi-
cantly increases lung fibroblast proliferation, migration
and differentiation to myofibroblasts. These findings were
associated with activation of the Wnt/β-catenin signaling
pathway. Additionally, we present evidence that TGF-β1
induces EMMPRIN expression in human lung fibroblasts.
Finally, we demonstrated that inhibition of EMMPRIN
using an EMMPRIN blocking antibody enhanced the
apoptotic susceptibility of lung fibroblasts. Further, block-
ing EMMPRIN functionally inhibited lung fibroblast pro-
liferation, migration, and differentiation to myofibroblasts
(See figure on previous page.)
Fig. 5 EMMPRIN functional blocking antibody induces apoptosis in normal human lung fibroblasts: NHLF treated for 24 h with TGF- β1 in the
presence of either EMMPRIN functional blocking antibody or IgG control antibody. Apoptosis was measured by (a) FACS analysis using annexin V/PI
staining; (b) Cell Death Detection ELISA assay, each bar represents means ± SEM of 3 independent experiments, each run in duplicate, ** p < 0.001
comparing EMMPRIN functional blocking antibody to IgG control antibody treated cells; and (c) Western blot for caspase- 3 of cell lysates from NHLF
treated with TGF-β1 (5 and 10 ng/ml) in the presence of EMMPRIN functional blocking antibody or IgG control antibody. β-Tubulin was used as the
loading control. Image is a representative of 3 independent experiments, each run in duplicate
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Fig. 6 (See legend on next page.)
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in response to TGF-β1. Collectively, these findings indi-
cate that increased EMMPRIN expression in the lung of
IPF patients represents one mechanism by which lung
fibroblasts acquire a proliferative, migratory and anti-
apoptotic phenotype.
The data presented here suggests that TGF- β1 increases
lung fibroblast proliferation, migration, and differentiation
into myofibroblasts via upregulation of EMMPRIN expres-
sion, which may be another potential mechanism to explain
the increased number of lung fibroblasts in pulmonary
fibrosis. Our results are in agreement with other recent
studies [22, 24] demonstrating that TGF-β1 contributes to
the upregulation of EMMPRIN in normal epithelial cells
and fibroblasts. Moreover, EMMPRIN, by inducing MMPs
releases activate TGF- β1, which further upregulates EMM-
PRIN and creates a positive feedback regulation that
potentially amplifies EMMPRIN’s effects [24, 34]. MMPs,
specifically MMP-2, -9 and MMP-14, have been reported
to activate TGF- β1 [14–18]. MMP-2 deficiency suppressed
the activation of latent TGF-β and the Smad2/3 pathway in
vivo and in vitro [17].
We also provide evidence that EMMPRIN overexpres-
sion induces resistance of NHLF to the apoptotic effects
of Staurosporine, a known inducer of apoptosis. The
EMMPRIN blocking antibody induced apoptosis of
NHLF treated with TGF- β1. These data suggest that
EMMPRIN acts as a fibroblast survival factor and TGF-
β1 increases survival of lung fibroblasts via upregulation
(See figure on previous page.)
Fig. 6 EMMPRIN blocking antibody attenuates TGF-β1 induced lung fibroblast proliferation, migration and differentiation to myofibroblast: NHLF
were stimulated with TGF-β1 (0-10 ng/ml) in the presence of either EMMPRIN functional blocking antibody or IgG control antibody examined for (a)
Cells proliferation using [3H] thymidine incorporation; (b) Cell migration using a modified Boyden chamber assay. Each bar represents means ± SEM of
3 independent experiments, each run in duplicate, # p = 0.002 or ** p < 0.001 comparing EMMPRIN functional blocking antibody to IgG control
antibody treated cells; and (c) Cell differentiation using Western blot for α-SMA of cell lysates from NHLF treated with TGF-β1 (5 and 10 ng/ml) in the
presence of either EMMPRIN functional blocking antibody or IgG antibody. β-Tubulin was used as the loading control. Image is a representative of 3
independent experiments, each run in duplicate
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Fig. 7 EMMPRIN Overexpression Increases Wnt/β-catenin signaling: (a) Representative Western blot for phosphorylated β-catenin of cells lysates
from NHLF overexpressing either EMMPRIN/GFP or GFP treated with and without TGF-β1 (10 ng/ml). β-Tubulin was used as the loading control.
Image is representative of 3 independent experiments, each run in duplicate. b Transient transfection of TOPFLASH, FOPFLASH, and control renilla
luciferase reporter constructs into NHLF overexpressing either EMMPRIN/GFP or GFP then treated with TGF-β1 10 ng/ml. Each bar represents
means ± SEM of 3 independent experiments, each run in duplicate, ** p < 0.001comparing GFP to EMMPRIN/GFP transfected cells
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of EMMPRIN expression in these cells. These findings
are supported by the report of Ma et al. [35] demon-
strating that cell–cell contact mediated by EMMPRIN
conferred apoptosis resistance in an E-cadherin
dependent manner and down regulation of EMMPRIN
inhibited cell–cell contact formation, which induced cell
apoptosis. Xie et al also demonstrated that EMMPRIN
overexpression protects human umbilical vein endothe-
lial cells (HUVECs) from apoptosis [36]. Other studies
have shown that EMMPRIN inhibits apoptosis by acti-
vating the FAK-PI3K-calcium (Ca2+) signaling pathway
by interacting with α3β1 integrin and disrupts the nitric
oxide /cGMP-mediated negative regulation of store-
operated calcium entry, thus increasing the intracellular
level of calcium [37]. The disruption of intracellular
calcium homeostasis can disturb endoplasmic reticulum
(ER) function and induce ER stress (ERS) [38].
We report in this study that EMMPRIN overexpres-
sion in NHLF induces fibroblast migration and EMM-
PRIN blocking antibody inhibits NHLF migration in
response to TGF- β1. These results are attributed to the
role of EMMPRIN in inducing MMPs and its interaction
with a number of binding partners on the cell surface,
including the hyaluronan receptor CD44 [39–43]. These
interactions are critical for regulating cell migration,
survival and proliferation, and events required in differ-
ent processes such as wound healing [44]. A study by
Toole and Slomiany [45] demonstrated that EMMPRIN
overexpression plays an important role in cell migration
and invasion via inducing hyaluronan (HA) production
[45]. Overexpression of HA synthase 2 (HAS2) by lung
fibroblasts produced an aggressive invasive phenotype
leading to severe lung fibrosis and death after bleomycin-
induced injury. Fibroblasts isolated from patients with IPF
exhibited an invasive phenotype that was also dependent
on HAS2 and CD44. EMMPRIN interaction with CD44
has been reported to potentiate cell survival pathways and
the invasive phenotype of epithelial cells. EMMPRIN also
promotes assembly of signaling complexes containing
EMMPRIN, CD44, and EGFR in lipid raft like domains
forming a positive feedback loop that may amplify in-
vasiveness of epithelial cells [46].
Moreover, we provide evidence that EMMPRIN over-
expression in NHLF promotes the differentiation of
fibroblasts into myofibroblasts by inducing α-SMA ex-
pression and EMMPRIN blocking antibody inhibits
TGF- β1 induced differentiation of fibroblasts to myofi-
broblasts. These data are supported by a previously
reported study showing that EMMPRIN induced corneal
fibroblast differentiation into myofibroblasts by inducing
α-SMA through MMP-independent mechanisms [22].
Blocking EMMPRIN expression by small interfering
RNA inhibited α-SMA and collagen gel contraction
induced not only by EMMPRIN but also by TGF-β1, a
major mediator of myofibroblast differentiation [22].
EMMPRIN and α- SMA were co-localized to the same
cells in the stroma of pathological tissue, thus support-
ing a role for EMMPRIN in the differentiation of myofi-
broblasts in vivo. These data suggest that in addition to
regulating the degradative potential of the myofibro-
blasts, EMMPRIN can also influence the contractile
phenotype of these cells in an MMP independent
manner and expand on the mechanism by which
EMMPRIN remodels ECM during wound healing and
tissue fibrosis.
Finally, we demonstrate that EMMPRIN overexpres-
sion in NHLF increased Wnt/β –catenin signaling, as
shown by increased β -catenin expression in EMMPRIN
overexpressing NHLF and increased TOPFLASH lucifer-
ase reporter activity. The Wnt/β catenin pathway is
thought to play a major role in pulmonary fibrosis.
Abnormal activation of Wnt/ β catenin pathway has been
demonstrated in lung tissue of patients with IPF [47] and
in an experimental model of bleomycin induced pulmon-
ary fibrosis [48]. MMPs especially MMP-2, -7, -9, -14 and
TGF – β1 have been known as Wnt/ β- catenin target
genes [49–51]. Supporting our data is a study by Sidhu
et al [26] demonstrating that EMMPRIN has a regula-
tory role over the Wnt/β -catenin signaling pathway.
Increasing EMMPRIN expression upregulated the β
-catenin signaling pathway and silencing EMMPRIN
inhibited β -catenin signaling, cell migration, prolifera-
tion, anchorage-independent growth and tumor growth
in a mouse tumor xenograft model [26].
Conclusion
The present study demonstrates that TGF-β1 induces the
release of EMMPRIN that in turn activates the β-catenin/
canonical Wnt signaling pathway. EMMPRIN over ex-
pression in human lung fibroblasts contributes to the
proliferative, migratory, and anti-apoptotic phenotype of
lung fibroblasts that may contribute to the persistent
fibro-proliferative state seen IPF. Further studies are
needed to explain the mechanism by which EMM-
PRIN mediates the phenotypic changes in human
lung fibroblasts and regulates TGF- β1 signaling.
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